Diagnostic and Prognostic Impact of Circulating YKL-40, IL-6, and CA 19.9 in Patients with Pancreatic Cancer

Cancer statistics, 2012

(2012) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment

(2012) Douglas Hanahan et al.   CANCER CELL

Interleukin-6 signaling pathway in targeted therapy for cancer

(2012) Yuqi Guo et al.   CANCER TREATMENT REVIEWS

Chitinase 3-like-1 Promotes Streptococcus pneumoniae Killing and Augments Host Tolerance to Lung Antibacterial Responses

(2012) Charles S. Dela Cruz et al.   Cell Host & Microbe

Role of Chitin and Chitinase/Chitinase-Like Proteins in Inflammation, Tissue Remodeling, and Injury

(2011) Chun Geun Lee et al.   Annual Review of Physiology

Hallmarks of Cancer: The Next Generation

(2011) Douglas Hanahan et al.   CELL

Plasma YKL-40 levels in healthy subjects from the general population

(2011) Stig E. Bojesen et al.   CLINICA CHIMICA ACTA

Stat3: Linking inflammation to (gastrointestinal) tumourigenesis

(2011) Matthias Ernst et al.   CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY

Carbohydrate-binding motif in chitinase 3-like 1 (CHI3L1/YKL-40) specifically activates Akt signaling pathway in colonic epithelial cells

(2011) Chun-Chuan Chen et al.   CLINICAL IMMUNOLOGY

IL-6, but not TNF-α, increases plasma YKL-40 in human subjects

(2011) Anders R. Nielsen et al.   CYTOKINE

Utility of Serum YKL-40 as a Tumor-Specific Marker of Hepatobiliary Malignancies

(2011) Ju Dong Yang et al.   Gut and Liver

Role of YKL-40 in the Angiogenesis, Radioresistance, and Progression of Glioblastoma

(2011) Ralph A. Francescone et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

YKL-40 Is Differentially Expressed in Human Embryonic Stem Cells and in Cell Progeny of the Three Germ Layers

(2011) Christian B. Brøchner et al.   JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY

A YKL-40-Neutralizing Antibody Blocks Tumor Angiogenesis and Progression: A Potential Therapeutic Agent in Cancers

(2011) M. Faibish et al.   MOLECULAR CANCER THERAPEUTICS

Genome-wide association study identifies five loci associated with susceptibility to pancreatic cancer in Chinese populations

(2011) Chen Wu et al.   NATURE GENETICS

Chitinase 3-like 1 promotes macrophage recruitment and angiogenesis in colorectal cancer

(2011) M Kawada et al.   ONCOGENE

Hallmarks of cancer: Interactions with the tumor stroma

(2010) Kristian Pietras et al.   EXPERIMENTAL CELL RESEARCH

Pancreatic Cancer

(2010) Manuel Hidalgo   NEW ENGLAND JOURNAL OF MEDICINE

YKL-40—A Protein in the Field of Translational Medicine: A Role as a Biomarker in Cancer Patients?

(2010) Nicolai A. Schultz et al.   Cancers

YKL-40 tissue expression and plasma levels in patients with ovarian cancer

(2009) Estrid VS Høgdall et al.   BMC CANCER

Plasma YKL-40: a potential new cancer biomarker?

(2009) Julia S Johansen et al.   Future Oncology

Role of breast regression protein 39 (BRP-39)/chitinase 3-like-1 in Th2 and IL-13–induced tissue responses and apoptosis

(2009) Chun Geun Lee et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Identification of a biomarker panel using a multiplex proximity ligation assay improves accuracy of pancreatic cancer diagnosis

(2009) Stephanie T Chang et al.   Journal of Translational Medicine

YKL-40, a secreted glycoprotein, promotes tumor angiogenesis

(2009) R Shao et al.   ONCOGENE

Potential role of chitinase 3-like-1 in inflammationassociated carcinogenic changes of epithelial cells

(2009) Katrin Eurich et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Pre-analytical and biological variability in circulating interleukin 6 in healthy subjects and patients with rheumatoid arthritis

(2008) Lene S. Knudsen et al.   BIOMARKERS

Elevated Plasma YKL-40 Predicts Increased Risk of Gastrointestinal Cancer and Decreased Survival After Any Cancer Diagnosis in the General Population

(2008) Julia S. Johansen et al.   JOURNAL OF CLINICAL ONCOLOGY